Non-European markets still constitute a major part of sales at AJ Vaccines, after the vaccine manufacturer, established three years ago, has had to note a decline in sales on the Danish home market as well as on other European markets, shows the company's 2019 report.
In Denmark, around one third of the revenue was shaved off from 2018 to 2019 with it landing on DKK 56m (USD 8.8m). For the rest of Europe, sales went from DKK 194m to DKK 109m.
Get full access for you and your coworkers.Start a free company trial today
Already a member? Log in.